Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Bases de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pathog Dis ; 822024 Feb 07.
Artigo em Inglês | MEDLINE | ID: mdl-38684476

RESUMO

We have demonstrated previously that TNF-α-producing CD8+ T cells mediate chlamydial pathogenesis, likely in an antigen (Ag)-specific fashion. Here we hypothesize that inhibition of Ag-specific CD8+ T cell response after immunization and/or challenge would correlate with protection against oviduct pathology induced by a protective vaccine regimen. Intranasal (i.n.) live chlamydial elementary body (EB), intramuscular (i.m.) live EB, or i.n. irrelevant antigen, bovine serum albumin (BSA), immunized animals induced near-total protection, 50% protection, or no protection, respectively against oviduct pathology following i.vag. C. muridarum challenge. In these models, we evaluated Ag-specific CD8+ T cell cytokine response at various time-periods after immunization or challenge. The results show protective efficacy of vaccine regimens correlated with reduction of Ag-specific CD8+ T cell TNF-α responses following i.vag. chlamydial challenge, not after immunization. Depletion of CD4+ T cells abrogated, whereas adoptive transfer of Ag-specific CD4+ T cells induced the significant reduction of Ag-specific CD8+ T cell TNF-α response after chlamydial challenge. In conclusion, protective anti-chlamydial vaccine regimens induce Ag-specific CD4+ T cell response that mediate early inhibition of pathogenic CD8+ T cell response following challenge and may serve as a predictive biomarker of protection against Chlamydia -induced chronic pathologies.


Assuntos
Vacinas Bacterianas , Linfócitos T CD4-Positivos , Linfócitos T CD8-Positivos , Infecções por Chlamydia , Animais , Linfócitos T CD8-Positivos/imunologia , Linfócitos T CD4-Positivos/imunologia , Infecções por Chlamydia/imunologia , Infecções por Chlamydia/prevenção & controle , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/administração & dosagem , Feminino , Camundongos , Modelos Animais de Doenças , Fator de Necrose Tumoral alfa/metabolismo , Chlamydia muridarum/imunologia
2.
Cureus ; 14(2): e21864, 2022 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-35155038

RESUMO

Stevens-Johnson syndrome (SJS) is a potentially life-threatening cutaneous disorder that is characterized by skin erosions. It lies on a spectrum of varying severity with toxic epidermal necrolysis (TEN) being the most severe form. An overlap of the syndromes is known as SJS/TEN. These disorders are most often caused by a drug reaction, with anti-epileptic drugs and sulfonamide drugs as the common offending agents. Rarely, the syndrome can be due to a reaction to carbonic anhydrase inhibitors such as methazolamide. When present in association with methazolamide, the syndrome has only been known to occur in patients of Asian descent with human leukocyte antigen (HLA) mutations. We present a case of methazolamide-associated Stevens-Johnson syndrome in a patient of Caucasian descent.

3.
Int J Dermatol ; 59(5): 525-534, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32157692

RESUMO

Integrins are the major family of cell adhesion receptors in humans and essential for a wide range of normal physiology, including formation and maintenance of tissue structure integrity, cell migration, proliferation, and differentiation. Integrins also play a prominent role in tumor growth and metastasis. Translational research has tried to define the contribution of integrins to the phenotypic aggressiveness of melanoma because such knowledge is clinically useful. For example, differential expression of integrins in primary cutaneous melanoma can be used to distinguish indolent from aggressive, prometastatic melanoma. Recent studies have shown that gene expression-based testing of patient-derived melanoma tissue is feasible, and molecular tests may fully replace interventional surgical methods such as sentinel lymph node biopsies in the future. Because of their central role in mediating invasion and metastasis, integrins are likely to be useful biomarkers. Integrins are also attractive candidate targets for interventional therapy. This article focuses on the role of integrins in melanoma and highlights recent advances in the field of translational research.


Assuntos
Biomarcadores Tumorais/análise , Integrinas/análise , Melanoma/diagnóstico , Neoplasias Cutâneas/diagnóstico , Biomarcadores Tumorais/metabolismo , Adesão Celular , Diagnóstico Diferencial , Intervalo Livre de Doença , Estudos de Viabilidade , Humanos , Integrinas/metabolismo , Melanoma/mortalidade , Melanoma/patologia , Invasividade Neoplásica/diagnóstico , Invasividade Neoplásica/patologia , Valor Preditivo dos Testes , Prognóstico , Biópsia de Linfonodo Sentinela , Pele/patologia , Neoplasias Cutâneas/mortalidade , Neoplasias Cutâneas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA